Anzeige
Mehr »
Login
Mittwoch, 13.11.2024 Börsentäglich über 12.000 News von 676 internationalen Medien
Kolumbiens nächster Kupferriese? Warum Investoren dieses 14.000-Meter-Bohrprogramm beobachten!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESSWIRE
866 Leser
Artikel bewerten:
(2)

ABB and Hydrogen Optimized to Explore Development of Large-Scale Green Hydrogen Production Systems

Finanznachrichten News

The two companies sign Memorandum of Understanding (MOU) to make green hydrogen a financially feasible option for customers across industries

COLLINGWOOD, ON / ACCESSWIRE / September 10, 2020 / Global technology company ABB and Hydrogen Optimized have agreed to jointly explore the development of large-scale green hydrogen production systems connected to the electrical grid to offer a clean, sustainable and affordable energy source.

Hydrogen Optimized has ambitions to use its high current water electrolysis technology at scale to produce green hydrogen for emerging clean applications across industries, including chemical, utility and transportation. ABB's hydrogen research team will explore electrical power supply optimization through projects involving ABB high power rectifier (HPR) systems.

Together, the companies plan to prove that Hydrogen Optimized's RuggedCell water electrolysis technology can be used to develop an integrated product solution based on a 100MW single module plant design concept.

ABB is a leading worldwide supplier of high power rectifiers for any industrial application, providing maximum availability, highest productivity and with a high priority on personnel safety. Within its HPR range, rectifier systems provide DC current in the range of 5,000A to 550,000A, as single or multiple units and as such can provide nearly unlimited current and voltage combinations and meet most plant specific requirements.

"ABB is a world leader in the control and electrification solutions designed for large-scale electrochemical processes," said Andrew T.B. Stuart, President and CEO of Hydrogen Optimized. "Such technology is an excellent fit with our patent pending RuggedCell. Together these technologies create a continuous reduction in the installed capital cost as the scale of the green hydrogen project increases.

"Our joint work will lay the foundations for single-plant sizes up to the hundreds of MWs input power range. Demonstrating the scalability of these two key components of a water electrolysis installation is vital to economic green hydrogen and we are excited about the potential benefits for customers."

The MoU signed by the companies formalizes the agreement to explore the implementation of a demonstration system as well as the preparation of a 100MW plant design and commercialization strategies.

"This project plays to our strengths of building large, highly efficient, customized HPR systems, pushing the boundaries of what is possible from one rectifier unit," said Charl Marais, Global Product Manager, Process Industries, ABB. "Based on our many years of experience in providing control and electrical system solutions for electrochemical industries, we understand that HPR systems have the characteristics required for successful large-scale project deployment.

"This collaboration advances the commercial availability and feasibility of large-scale green hydrogen systems. We have been exploring this type of project for more than two years and the synergies with Hydrogen Optimized have been very apparent. We have a clear vision, and the results could be significant."

Applications using green hydrogen include zero emission transportation fuel supply, ammonia and other chemical production with non-fossil sources of hydrogen, and green metal production with hydrogen instead of a coking-type process.

Hydrogen Optimized, founded in 2017, is a private hydrogen technology company commercializing proprietary green hydrogen production systems. Our vision is that by 2030, the adoption of clean hydrogen processes for energy, chemical, and industrial purposes, will improve the quality of life for all individuals worldwide. Our pedigree dates to 1905 when Alexander T. Stuart, Canada's hydrogen pioneer, concluded that hydrogen and oxygen were the key building blocks to a sustainable clean energy and industrial world. With the world's premier hydrogen heritage, we develop, design, and build green hydrogen systems. We implement these with our partners and customers. www.hydrogenoptimized.com.

ABB (ABBN: SIX Swiss Ex) is a leading global technology company that energizes the transformation of society and industry to achieve a more productive, sustainable future. By connecting software to its electrification, robotics, automation and motion portfolio, ABB pushes the boundaries of technology to drive performance to new levels. With a history of excellence stretching back more than 130 years, ABB's success is driven by about 110,000 talented employees in over 100 countries. www.abb.com

For more information please contact:

ABB Ltd

Chris Brand
Phone: +44 (0)7523 919978
Email: chris.g.brand@gb.abb.com
Affolternstrasse 44 8050 Zurich Switzerland
www.ABB.com

Hydrogen Optimized Inc.

Harry De Rose
Phone: 1 705 444 7992 ext 101
Email: Harry.derose@hydrogenoptimized.com
40 Sandford Fleming Drive Collingwood ON, Canada L9Y 4V7
www.HydrogenOptimized.com

SOURCE: Hydrogen Optimized



View source version on accesswire.com:
https://www.accesswire.com/605573/ABB-and-Hydrogen-Optimized-to-Explore-Development-of-Large-Scale-Green-Hydrogen-Production-Systems

© 2020 ACCESSWIRE
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.